Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
BCMA-mRNA vaccine encapsulated in LNPs with poly(I:C) as TLR3 agonist is internalized by dendritic cells in vitro and leads to BCMA-specific CD8+ CTL and in vivo anti-myeloma response in two mouse myeloma models.”
Title: A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma
Authors: Debasmita Dutta, Jiye Liu, Kenneth Wen, Arghya Ray, Alessandro Salatino, Xiangdong Liu, Annamaria Gulla, Teru Hideshima, Yan Song, Kenneth C. Anderson
You can read the Full Article in Blood.
You can find more posts featuring Robert Orlowski in OncoDaily.
